Sign in
CompletedNo phase

Genomics of Posttraumatic Stress Disorder in Veterans

Key facts

Who runs it
VA Office of Research and Development
Where
San Diego, United StatesSee the site
Trial code
Status
Completed
People taking part
20,000 people enrolled
Started
1 Dec 2013
Ended
30 Sept 2024
Type of study
Observational
Record updated
3 October 2024

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Combat-exposed Veterans who participated in the Million Veteran Program

Who cannot take part

  • bipolar disorder
  • schizophrenia

Where in United States

  • VA San Diego Healthcare System, San Diego, CASan Diego, United States

About the trial

What the trial wants to find out

Posttraumatic Stress Disorder (PTSD), as a common and serious mental health condition, affects about 25% of all military personnel that have served in combat. People suffering from PTSD may experience traumatic flashbacks, trouble sleeping, and problems in their relationships. This study is intended to help identify genes that influence and increase the risk of PTSD, to improve ways of detecting and treating the condition in the future.

Read full original descriptionShow less

Previous research has studied genes that increase the risk of PTSD, but none of these have included a Veteran-only population. The current study focuses on US Veterans, utilizing the VA Million Veteran Program (MVP) database of approximately 300,000 participants as of August 2014. In this context, participants with PTSD are referred to as "cases" and Veterans without PTSD are referred to as "controls."

This project will be done in three stages. The first stage will look at MVP-obtained data and electronic health record (EHR) data to implement methods for identifying combat-exposed case patients with PTSD and combat-exposed control patients without PTSD. The second stage will assemble and validate a study population of 20,000 participants "including 10,000 combat-exposed Veterans with PTSD as cases and 10,000 combat-exposed Veterans without PTSD as controls. The third stage will conduct genetic analyses ("genotyping") comparing the cases to controls, to identify genes associated with increased risk of developing the condition.

The group in the trial

  • Million Veteran Program (MVP) participants

    Veterans who are currently enrolled in the Million Veteran Program.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
CSP #575B - Genomics of Posttraumatic Stress Disorder Among Veterans
Publications
Record updated
3 October 2024